Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
can008 (2 trials)
can106 (1 trial)
Glioblastoma (Phase 2)
Trials (3 total)
Trial APIs (2 total)